This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Glycotope Biotechnology Gmbh, Orpegen Medizinisch-Molekularbiologische Forschungsgesellschaft M.b.h., Orpegen Pharma Gmbh. Active years: 1992-2013.
Company Filing History:
1 out of 1 
1 out of 3 
1 out of 2 Years Active: 1992-2013
Title: The Innovations of Carl Thomas Nebe
Introduction
Carl Thomas Nebe is a notable inventor based in Ladenburg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the study of leukocytes and allergic responses. With a total of 3 patents, Nebe's work has advanced our understanding of immune responses and diagnostic methods.
Latest Patents
Nebe's latest patents include a method for determining the chemotactic activity of leukocytes in a sample, which involves assessing the expression of a cell adhesion molecule. This innovative approach has the potential to enhance diagnostic accuracy in various medical conditions. Another significant patent is the basophil degranulation test, which focuses on determining the degranulation activity of basophilic granulocytes. This invention also includes a reagent kit suitable for diagnosing allergic hypersensitivity and monitoring responses to hyposensitization therapy.
Career Highlights
Throughout his career, Carl Thomas Nebe has worked with several prominent companies, including Orpegen Medizinisch-Molekularbiologische Forschungsgesellschaft M.b.h. and Glycotope Biotechnology GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Nebe has collaborated with notable individuals in his field, including Werner Nader and Gerhard Nebe. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Carl Thomas Nebe's contributions to medical diagnostics through his innovative patents demonstrate his commitment to advancing healthcare. His work continues to influence the field and improve diagnostic methods for allergic conditions.